Global Inhaled Nitric Oxide Market Insights - Industry Share, Sales Projections, and Demand Outlook 2024-2030-NortonLifeLock,Experian,Equifax

Nitric oxide is a chemical compound in gas form that is sometimes used to treat infants with severe breathing problems associated with narrow blood vessels in the lungs. It works by relaxing smooth muscle to widen (dilate) blood vessels, especially in the lungs. Nitric oxide is usually used together with a breathing machine (ventilator).

Inhaled nitric oxide (iNO) is recognized as a potent and selective pulmonary vasodilator that does not decrease systemic vascular tone. The therapeutic application of iNO in human was first described in 1990s. INO therapy was effective to improve oxygenation in infants with persistent pulmonary hypertension of the newborn (PPHN). Owing to its selective pulmonary vasodilator effects, iNO therapy is an important treatment for term newborns with hypoxemic respiratory failure due to PPHN. The Food and Drug Administration of the United States of America first approved iNO in 1999 for use as a medical gas to treat hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in term and late preterm neonates. Thereafter, iNO therapy is clinically applied to treat PPHN in term and late preterm neonates without consensus.

The global Inhaled Nitric Oxide market was valued at US$ 1182 million in 2023 and is anticipated to reach US$ 2049 million by 2030, witnessing a CAGR of 8.3% during the forecast period 2024-2030. 

Get Sample Copy of This  Report https://www.qyresearch.in/request-sample/pharma--healthcare-global-inhaled-nitric-oxide-market-insights-industry-share-sales-projections-and-demand-outlook-2024-2030/

 
Mallinckrodt monopolizes the global Inhaled Nitric Oxide market, holding a share about 65%.

North America is the largest market, with a share about 77%, followed by Asia-Pacific and Europe, have a share about 20 percent.

In terms of product, 800 ppm is the largest segment, with a share over 50%. And in terms of application, the largest application is Near-term and Pre-term Infants PPHN, followed by Children and Adult ARDS, etc.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Inhaled Nitric Oxide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inhaled Nitric Oxide.

The Inhaled Nitric Oxide market size, estimations, and forecasts are provided in terms of sales quantity (M L) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Inhaled Nitric Oxide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Inhaled Nitric Oxide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

Mallinckrodt

Praxair (Linde plc)

Air Liquide

BOC Healthcare (Linde Group)

Segment by Type

800 ppm

100 ppm

Others

Segment by Application

Near-term and Pre-term Infants PPHN

Children and Adult ARDS

Other Diseases

By Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

U.A.E

Chapter Outline:

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: key insights, key emerging trends, etc.

Chapter 3: Manufacturers competitive analysis, detailed analysis of Inhaled Nitric Oxide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 5 & 6: Sales, revenue of Inhaled Nitric Oxide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: The main points and conclusions of the report.

Request Pre_Order Inquiry : https://www.qyresearch.in/pre-order-inquiry/pharma--healthcare-global-inhaled-nitric-oxide-market-insights-industry-share-sales-projections-and-demand-outlook-2024-2030/

 

Contact Us
QY RESEARCH, INC.
17890 CASTLETON STREET
SUITE 369, CITY OF INDUSTRY
CA - 91748, UNITED STATES OF AMERICA
+1 626 539 9760 / +91 8669986909
hitesh@qyresearch.com / enquiry@qyresearch.com

About Us 

QYResearch is a leading global market research and consulting company established in 2007. With over 16 years' experience and professional research team in various cities over the world QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability.

 

This release was published on openPR.